First Wave BioPharma Inc (FWBI)
NASDAQ
The current FWBI market cap is 2M. The company's latest EPS is USD -23.8563 and P/E is -0.12.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -3.42M | -4.09M | -9.23M | -3.3M | -1.89M |
Net Income | -3.48M | -4.18M | 5.5M | -8.85M | -2.63M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 8.09M | 0 |
Operating Income | -14.74M | -26.43M | -59.06M | -12.68M | -15.77M |
Net Income | -15.18M | -32.67M | -58.54M | -14.97M | -16.1M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 5.93M | 6.88M | 91.13M | 86.29M | 85.82M |
Total Liabilities | 2.65M | 3.28M | 13.27M | 15.49M | 15.77M |
Total Equity | 3.28M | 3.6M | 16.18M | 9.12M | 8.37M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 8.9M | 12.92M | 11.79M | 5.44M | 6.88M |
Total Liabilities | 4.29M | 15.57M | 19.61M | 2.7M | 3.28M |
Total Equity | 4.62M | -2.64M | -7.82M | 2.74M | 3.6M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -8.94M | -12.38M | -3.75M | -7.2M | -9.05M |
Investing | N/A | -500k | 88k | 88k | 88k |
Financing | 10.87M | 15.23M | 3.38M | 4.06M | 5.61M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -14.03M | -11.22M | -32.29M | -22.34M | -12.38M |
Investing | -24k | 88k | -10.32M | N/A | -500k |
Financing | 13.15M | 17.05M | 44.76M | 15.74M | 15.23M |
Market Cap | 2M |
Price to Earnings Ratio | -0.12 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.54 |
Price to Book Ratio | 0.55 |
Dividend Yield | - |
Shares Outstanding | 675k |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.19 (6.23%) |
Company Name | First Wave BioPharma Inc |
Address |
850 new burton road dover, delaware 19904 |
Website | https://www.enterothera.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.